4-[5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine
Product Information
Molecular Formula
C15H23BN2O3
Molecular Weight
290.166
Description
4-[5-(tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine plays a crucial role in the development of potential drugs for treating specific diseases. Its unique chemical structure enables targeted interactions with specific receptors or enzymes involved in diseases like cancer, inflammation, or neurological disorders.
Synonyms
1-[5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine
IUPAC Name
4-[5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl]morpholine
SMILES
B1(OC(C(O1)(C)C)(C)C)C2=CN=C(C=C2)N3CCOCC3
InChI
InChI=1S/C15H23BN2O3/c1-14(2)15(3,4)21-16(20-14)12-5-6-13(17-11-12)18-7-9-19-10-8-18/h5-6,11H,7-10H2,1-4H3
InChI Key
ZGDLVKWIZHHWIR-UHFFFAOYSA-N
Melting Point
135-139 °C (lit.)
Flash Point
Not applicable
Purity
97%
Computed Properties
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
2
Exact Mass
290.1801728 g/mol
Monoisotopic Mass
290.1801728 g/mol
Topological Polar Surface Area
43.8Ų
Heavy Atom Count
21
Formal Charge
0
Complexity
356
Isotope Atom Count
0
Defined Atom Stereocenter Count
0
Undefined Atom Stereocenter Count
0
Defined Bond Stereocenter Count
0
Undefined Bond Stereocenter Count
0
Covalently-Bonded Unit Count
1
Compound Is Canonicalized
Yes
Patents
| Publication Number | Title | Priority Date |
|---|---|---|
| WO-2021194326-A1 | Aminopyrimidine derivatives and their use as aryl hydrocarbon receptor modulators | 2020-03-27 |
| US-2021106588-A1 | Bicyclic heterocycles as fgfr inhibitors | 2019-10-14 |
| WO-2021076602-A1 | Bicyclic heterocycles as fgfr inhibitors | 2019-10-14 |
| TW-202128685-A | Bicyclic heterocycles as fgfr inhibitors | 2019-10-14 |
| WO-2021023813-A1 | 5-heteroaryl-pyridin-2-amine confounds as neuropeptide ff receptor antagonists | 2019-08-06 |
| WO-2020247804-A1 | Heterocycle substituted pyridine derivative antifungal agents | 2019-06-07 |
| WO-2020121261-A1 | 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same | 2018-12-14 |
| WO-2020121263-A1 | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same | 2018-12-14 |
| US-2020223827-A1 | 3,3-difluoroallylamines or salts thereof and pharmaceutical compositions comprising the same | 2018-12-14 |
| US-2020223844-A1 | Triazolopyridin-3-ones or their salts and pharmaceutical compositions comprising the same | 2018-12-14 |
